Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald L Klein

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Neuroscience Research|July 10, 2002
Pre- and post-synaptic modification by neurotrophinsMasami Kojima, Ronald L Klein, Hiroshi Hatanaka
Gene Therapy|July 18, 2018
More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.BRobert D Dayton, Mychal S Grames, Ronald L Klein
Expert Opinion on Biological Therapy|April 24, 2012
The advent of AAV9 expands applications for brain and spinal cord gene deliveryRobert D Dayton, David B Wang, Ronald L Klein
Neurotoxicity Research|August 12, 2009
Versatile somatic gene transfer for modeling neurodegenerative diseasesRonald L Klein, David B Wang, Michael A King
Molecular Therapy. Methods & Clinical Development|October 8, 2015
AAV9 supports wide-scale transduction of the CNS and TDP-43 disease modeling in adult ratsKasey L Jackson, Robert D Dayton, Ronald L Klein
Methods (San Diego, Calif.)|November 5, 2002
Gene delivery to the eye using adeno-associated viral vectorsKeith R G Martin, Ronald L Klein, Harry A Quigley
Methods (San Diego, Calif.)|November 5, 2002
Particle detection, number estimation, and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysisMichael A King, Nicole Scotty, Ronald L Klein, et al.
Neuroscience Letters|March 24, 2006
Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration modelRonald L Klein, Robert D Dayton, Karen M Henderson, et al.
Human Gene Therapy|March 28, 2002
Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigraRonald L Klein, Michael A King, Mary E Hamby, et al.
Experimental Neurology|March 30, 2010
Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory responseDavid B Wang, Robert D Dayton, Richard M Zweig, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Neuroscience Research|July 10, 2002
Pre- and post-synaptic modification by neurotrophinsMasami Kojima, Ronald L Klein, Hiroshi Hatanaka
Gene Therapy|July 18, 2018
More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.BRobert D Dayton, Mychal S Grames, Ronald L Klein
Expert Opinion on Biological Therapy|April 24, 2012
The advent of AAV9 expands applications for brain and spinal cord gene deliveryRobert D Dayton, David B Wang, Ronald L Klein
Neurotoxicity Research|August 12, 2009
Versatile somatic gene transfer for modeling neurodegenerative diseasesRonald L Klein, David B Wang, Michael A King
Molecular Therapy. Methods & Clinical Development|October 8, 2015
AAV9 supports wide-scale transduction of the CNS and TDP-43 disease modeling in adult ratsKasey L Jackson, Robert D Dayton, Ronald L Klein
Methods (San Diego, Calif.)|November 5, 2002
Gene delivery to the eye using adeno-associated viral vectorsKeith R G Martin, Ronald L Klein, Harry A Quigley
Methods (San Diego, Calif.)|November 5, 2002
Particle detection, number estimation, and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysisMichael A King, Nicole Scotty, Ronald L Klein, et al.
Neuroscience Letters|March 24, 2006
Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration modelRonald L Klein, Robert D Dayton, Karen M Henderson, et al.
Human Gene Therapy|March 28, 2002
Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigraRonald L Klein, Michael A King, Mary E Hamby, et al.
Experimental Neurology|March 30, 2010
Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory responseDavid B Wang, Robert D Dayton, Richard M Zweig, et al.
Pageof 7